NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球精準醫療市場:按類型(治療、診斷、個性化醫療)-行業分析和增長預測(至 2030 年)

Precision Medicine Market Research Report: By Type (Therapeutics, Diagnostics, Personalized Medical Care) - Global Industry Analysis and Growth Forecast to 2030

出版商 Prescient & Strategic Intelligence Private Limited 商品編碼 1007636
出版日期 內容資訊 英文 280 Pages
商品交期: 2-3個工作天內
價格
全球精準醫療市場:按類型(治療、診斷、個性化醫療)-行業分析和增長預測(至 2030 年) Precision Medicine Market Research Report: By Type (Therapeutics, Diagnostics, Personalized Medical Care) - Global Industry Analysis and Growth Forecast to 2030
出版日期: 2021年03月01日內容資訊: 英文 280 Pages
簡介

全球精準醫療市場預計從 2020 年到 2030 年以 12.1% 的複合年增長率增長,從 2019 年的 2035 億美元到 2030 年增長到 7388 億美元。在全球精準醫療市場中,由於新型冠狀病毒感染(COVID-19)的患者人數和死亡人數的增加以及針對每位患者量身定制的治療方法,對有效治療的需求正在迅速增加。開通研發建立。

本報告調查了全球精準醫療市場,按類型/地區對市場規模、趨勢和市場規模進行了概述,分析了市場增長和製約因素、市場機會、競爭條件和主要因素。它總結了公司概況和很快。

目錄

第 1 章調查背景

第 2 章調查方法

第 3 章執行摘要

第 4 章介紹

  • 細分市場的定義
    • 按類型
      • 治療藥物
      • 診斷
      • 個性化醫療
  • 市場動態
    • 市場趨勢
      • 精準醫學臨床試驗數量增加
    • 促進因素
      • 增加政府支持
      • 批准的個性化藥物增加
      • 不斷發展的醫療旅遊產業
      • 人工智能在精準醫療中的使用迅速增加
      • 促進因素影響分析
    • 抑制因素
      • 精準醫療研發成本高
      • 兌換政策
      • 抑製器的影響分析
    • 市場機會
  • 新型冠狀病毒感染 (COVID-19) 的影響
  • 五力分析

第 5 章全球精準醫療市場:市場規模和預測

  • 按類型
    • 精準醫學診斷
    • 個性化醫療
      • 遠程醫療:按服務
      • 遠程醫療:性別
  • 按地區

第 6 章北美精準醫療市場:市場規模及預測

  • 按類型
  • 按國家/地區
    • 美國
    • 加拿大

第 7 章歐洲精準醫療市場:市場規模和預測

  • 按類型
  • 按國家/地區
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙

第八章亞太精準醫療市場:市場規模及預測

  • 按類型
  • 按國家/地區
    • 日本
    • 中國
    • 印度

第 9 章拉丁美洲精準醫療市場:市場規模和預測

  • 按類型
  • 按國家/地區

第 10 章中東和非洲精準醫療市場:市場規模及預測

  • 按類型
  • 按國家/地區

第 11 章競爭形勢

  • 各大公司產品標桿
  • 主要公司戰略發展趨勢
    • 產品批准/發佈
    • 夥伴合作
    • 其他

第 12 章公司簡介

  • Myriad Genetics Inc.
  • Pacific Biosciences of California Inc.
  • Partek Inc.
  • Randox Laboratories Ltd.
  • Menarini Silicon Biosystems S.p.a.
  • Oracle Corporation
  • 23andMe Inc.
  • Precision BioLogic Incorporated
  • EPIC SCIENCES INC.
  • Intomics
  • MDxHealth SA
  • Asuragen Inc.
  • Almac Group Limited
  • International Business Machines Corporation
  • Bristol-Myers Squibb Company
  • Johnson & Johnson
  • Eli Lilly and Company
  • Sanofi
  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • bioMerieux S.A.
  • General Electric Company
  • Thermo Fisher Scientific Inc.

第 13 章附錄

目錄
Product Code: LS12170

In July 2019, U.S. president Donald Trump decided to bring down the prices of drugs in the country to make them equal or similar to the international rates. This move was made with a specific eye on the evolving field of precision medicine. Therefore, with such government efforts around the world, the global precision medicine market size is expected to grow at a 12.1% CAGR between 2020 and 2030, to reach $738.8 billion by 2030 from $203.5 billion in 2019, according to P&S Intelligence.

Similarly, in 2017, a grant was established by the Argentine government to bring the experimental precision medicine practices to the clinical field. Another such move that is benefitting the precision medicine market advance is the 2015 investment of $215 million by the U.S. government in this field to find a better cure for lung cancer, colorectal cancer, breast cancer, and several other diseases. In the same vein, the government of Hong Kong plans to monitor cancer patients and use precision medicines for better outcomes.

The COVID-19 pandemic is acting as a precision medicine market growth driver, as the surging number of cases and deaths has drastically raised the demand for an effective treatment. Moreover, with different people reacting differently to the disease, which has been characterized by wide-ranging complications, research and development (R&D) activities to come up with personalized treatments have picked pace.

In the past, the precision medicine market was dominated by the therapeutics category, on the basis of type. The technological advancements in the field of gene therapy, along with the various benefits such a treatment offers, are propelling the demand for precision medicines

In the coming years, the telemedicine category will continue to hold the largest share in the precision medicine market, based on the type of personalized medical care. The healthcare sector is quickly adopting telemedicine to widen the access to medical services and reduce the burden on the staff.

Historically, North America was the largest precision medicine market as a result of the rising incidence of lifestyle-associated and chronic diseases, including cancer, cardiovascular diseases (CVDs), and diabetes, and high disposable income of people. Additionally, the region is home to a large number of medical researchers who are extensively studying the potential applications of precision medicine. Moreover, the government here is offering grants and conducting awareness-raising programs.

The highest CAGR in the precision medicine market in the years to come is projected to be experienced in the Asia-Pacific (APAC) region. The increasing government and private funding in the field, improving healthcare infrastructure, and rising purchasing power are propelling the market here. Additionally, market players are coming up with better precision medicine products, including those integrated with artificial intelligence (AI), to improve the overall patient outcomes.

The most-prominent companies in the global precision medicine market are Myriad Genetics Inc., Partek Inc., Pacific Biosciences of California Inc., Randox Laboratories Ltd., Oracle Corporation, Menarini Silicon Biosystems S.p.a., 23andMe Inc., EPIC SCIENCES INC., Precision BioLogic Incorporated, MDxHealth SA, General Electric Company, Intomics, Asuragen Inc., International Business Machines (IBM) Corporation, Almac Group Limited, Bristol-Myers Squibb Company, Eli Lilly and Company, Johnson & Johnson, Sanofi, Bio-Rad Laboratories Inc., Abbott Laboratories, Danaher Corporation, bioMerieux S.A., F. Hoffmann-La Roche Ltd., and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1. Research Background

  • 1.1 Research Objectives
  • 1.2 Market Definition
  • 1.3 Research Scope
    • 1.3.1 Market Segmentation by Type
    • 1.3.2 Market Segmentation by Region
    • 1.3.3 Analysis Period
    • 1.3.4 Market Data Reporting Unit
      • 1.3.4.1 Value
  • 1.4 Key Stakeholders

Chapter 2. Research Methodology

  • 2.1 Secondary Research
  • 2.2 Primary Research
    • 2.2.1 Breakdown of Primary Research Respondents
      • 2.2.1.1 By region
      • 2.2.1.2 By industry participant
      • 2.2.1.3 By company type
  • 2.3 Market Size Estimation
  • 2.4 Data Triangulation
  • 2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

  • 4.1 Definition of Market Segments
    • 4.1.1 By Type
      • 4.1.1.1 Therapeutics
      • 4.1.1.2 Diagnostics
        • 4.1.1.2.1 Esoteric lab services
        • 4.1.1.2.2 Esoteric tests
        • 4.1.1.2.3 Molecular diagnostics
      • 4.1.1.3 Personalized medical care
        • 4.1.1.3.1 EMR
        • 4.1.1.3.2 Telemedicine
        • 4.1.1.3.2.1 By service
        • 4.1.1.3.2.1.1 Tele consulting
        • 4.1.1.3.2.1.2 Tele monitoring
        • 4.1.1.3.2.1.3 Tele education
        • 4.1.1.3.2.1.4 Tele training
        • 4.1.1.3.2.1.5 Others
        • 4.1.1.3.2.2 By specialty
        • 4.1.1.3.2.2.1 Dermatology
        • 4.1.1.3.2.2.2 Gynecology
        • 4.1.1.3.2.2.3 Cardiology
        • 4.1.1.3.2.2.4 Neurology
        • 4.1.1.3.2.2.5 Orthopedics
        • 4.1.1.3.2.2.6 Others
        • 4.1.1.3.3 DM
  • 4.2 Market Dynamics
    • 4.2.1 Trends
      • 4.2.1.1 Increasing number of clinical trials for precision medicine
    • 4.2.2 Drivers
      • 4.2.2.1 Increasing government support
      • 4.2.2.2 Rising number of approved personalized medicine
      • 4.2.2.3 Growing medical tourism industry
      • 4.2.2.4 Surging use of AI in precision medicine
      • 4.2.2.5 Impact analysis of drivers on market forecast
    • 4.2.3 Restraints
      • 4.2.3.1 High cost for developing a precision medicine
      • 4.2.3.2 Reimbursement policies
      • 4.2.3.3 Impact analysis of restraints on market forecast
    • 4.2.4 Opportunities
      • 4.2.4.1 Companies across APAC are showing interest toward the development of new precision medicine
  • 4.3 Impact of COVID-19
    • 4.3.1 Supply Side Analysis
      • 4.3.1.1 Current scenario of major key players offerings precision medicines
      • 4.3.1.2 Situation of lockdown and workforce availability
      • 4.3.1.3 Production scenario
      • 4.3.1.4 Situation of major countries supplying precision medicines
    • 4.3.2 Demand Side Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Intensity of Rivalry
    • 4.4.4 Threat of New Entrants
    • 4.4.5 Threat of Substitutes

Chapter 5. Global Market Size and Forecast

  • 5.1 By Type
    • 5.1.1 Precision Medicine Diagnostics Market, by Type
    • 5.1.2 Personalized Medical Care Market, by Type
      • 5.1.2.1 Telemedicine market, by service
      • 5.1.2.2 Telemedicine market, by specialty
  • 5.2 By Region

Chapter 6. North America Market Size and Forecast

  • 6.1 By Type
    • 6.1.1 Precision Medicine Diagnostics Market, by Type
    • 6.1.2 Personalized Medical Care Market, by Type
      • 6.1.2.1 Telemedicine market, by service
      • 6.1.2.2 Telemedicine market, by specialty
  • 6.2 By Country
    • 6.2.1 U.S. Precision Medicine Market
      • 6.2.1.1 By type
        • 6.2.1.1.1 Precision medicine diagnostics market, by type
        • 6.2.1.1.2 Personalized medical care market, by type
        • 6.2.1.1.2.1 Telemedicine market, by service
        • 6.2.1.1.2.2 Telemedicine market, by specialty
    • 6.2.2 Canada Precision Medicine Market
      • 6.2.2.1 By type
        • 6.2.2.1.1 Precision medicine diagnostics market, by type
        • 6.2.2.1.2 Personalized medical care market, by type
        • 6.2.2.1.2.1 Telemedicine market, by service
        • 6.2.2.1.2.2 Telemedicine market, by specialty

Chapter 7. Europe Market Size and Forecast

  • 7.1 By Type
    • 7.1.1 Precision Medicine Diagnostics Market, by Type
    • 7.1.2 Personalized Medical Care Market, by Type
      • 7.1.2.1 Telemedicine market, by service
      • 7.1.2.2 Telemedicine market, by specialty
  • 7.2 By Country
    • 7.2.1 Germany Precision Medicine Market
      • 7.2.1.1 By type
        • 7.2.1.1.1 Precision medicine diagnostics market, by type
        • 7.2.1.1.2 Personalized medical care market, by type
        • 7.2.1.1.2.1 Telemedicine market, by service
        • 7.2.1.1.2.2 Telemedicine market, by specialty
    • 7.2.2 France Precision Medicine Market
      • 7.2.2.1 By type
        • 7.2.2.1.1 Precision medicine diagnostics market, by type
        • 7.2.2.1.2 Personalized medical care market, by type
        • 7.2.2.1.2.1 Telemedicine market, by service
        • 7.2.2.1.2.2 Telemedicine market, by specialty
    • 7.2.3 U.K. Precision Medicine Market
      • 7.2.3.1 By type
        • 7.2.3.1.1 Precision medicine diagnostics market, by type
        • 7.2.3.1.2 Personalized medical care market, by type
        • 7.2.3.1.2.1 Telemedicine market, by service
        • 7.2.3.1.2.2 Telemedicine market, by specialty
    • 7.2.4 Italy Precision Medicine Market
      • 7.2.4.1 By type
        • 7.2.4.1.1 Precision medicine diagnostics market, by type
        • 7.2.4.1.2 Personalized medical care market, by type
        • 7.2.4.1.2.1 Telemedicine market, by service
        • 7.2.4.1.2.2 Telemedicine market, by specialty
    • 7.2.5 Spain Precision Medicine Market
      • 7.2.5.1 By type
        • 7.2.5.1.1 Precision medicine diagnostics market, by type
        • 7.2.5.1.2 Personalized medical care market, by type
        • 7.2.5.1.2.1 Telemedicine market, by service
        • 7.2.5.1.2.2 Telemedicine market, by specialty

Chapter 8. APAC Market Size and Forecast

  • 8.1 By Type
    • 8.1.1 Precision Medicine Diagnostics Market, by Type
    • 8.1.2 Personalized Medical Care Market, by Type
      • 8.1.2.1 Telemedicine market, by service
      • 8.1.2.2 Telemedicine market, by specialty
  • 8.2 By Country
    • 8.2.1 Japan Precision Medicine Market
      • 8.2.1.1 By type
        • 8.2.1.1.1 Precision medicine diagnostics market, by type
        • 8.2.1.1.2 Personalized medical care market, by type
        • 8.2.1.1.2.1 Telemedicine market, by service
        • 8.2.1.1.2.2 Telemedicine market, by specialty
    • 8.2.2 China Precision Medicine Market
      • 8.2.2.1 By type
        • 8.2.2.1.1 Precision medicine diagnostics market, by type
        • 8.2.2.1.2 Personalized medical care market, by type
        • 8.2.2.1.2.1 Telemedicine market, by service
        • 8.2.2.1.2.2 Telemedicine market, by specialty
    • 8.2.3 India Precision Medicine Market
      • 8.2.3.1 By type
        • 8.2.3.1.1 Precision medicine diagnostics market, by type
        • 8.2.3.1.2 Personalized medical care market, by type
        • 8.2.3.1.2.1 Telemedicine market, by service
        • 8.2.3.1.2.2 Telemedicine market, by specialty

Chapter 9. LATAM Market Size and Forecast

  • 9.1 By Type
    • 9.1.1 Precision Medicine Diagnostics Market, by Type
    • 9.1.2 Personalized Medical Care Market, by Type
      • 9.1.2.1 Telemedicine market, by service
      • 9.1.2.2 Telemedicine market, by specialty
  • 9.2 By Country

Chapter 10. MEA Market Size and Forecast

  • 10.1 By Type
    • 10.1.1 Precision Medicine Diagnostics Market, by Type
    • 10.1.2 Personalized Medical Care Market, by Type
      • 10.1.2.1 Telemedicine market, by service
      • 10.1.2.2 Telemedicine market, by specialty
  • 10.2 By Country

Chapter 11. Competitive Landscape

  • 11.1 Product Benchmarking of Key Players
  • 11.2 Strategic Developments of Key Players
    • 11.2.1 Product Launches and Approvals
    • 11.2.2 Partnerships and Collaborations
    • 11.2.3 Others

Chapter 12. Company Profiles

  • 12.1 Myriad Genetics Inc.
    • 12.1.1 Business Overview
    • 12.1.2 Product and Service Offerings
    • 12.1.3 Key Financial Summary
  • 12.2 Pacific Biosciences of California Inc.
    • 12.2.1 Business Overview
    • 12.2.2 Key Financial Summary
  • 12.3 Partek Inc.
    • 12.3.1 Business Overview
  • 12.4 Randox Laboratories Ltd.
    • 12.4.1 Business Overview
    • 12.4.2 Product and Service Offerings
  • 12.5 Menarini Silicon Biosystems S.p.a.
    • 12.5.1 Business Overview
    • 12.5.2 Product and Service Offerings
  • 12.6 Oracle Corporation
    • 12.6.1 Business Overview
    • 12.6.2 Product and Service Offerings
    • 12.6.3 Key Financial Summary
  • 12.7 23andMe Inc.
    • 12.7.1 Business Overview
    • 12.7.2 Product and Service Offerings
  • 12.8 Precision BioLogic Incorporated
    • 12.8.1 Business Overview
    • 12.8.2 Product and Service Offerings
  • 12.9 EPIC SCIENCES INC.
    • 12.9.1 Business Overview
    • 12.9.2 Product and Service Offerings
  • 12.10 Intomics
    • 12.10.1 Business Overview
    • 12.10.2 Product and Service Offerings
  • 12.11 MDxHealth SA
    • 12.11.1 Business Overview
    • 12.11.2 Product and Service Offerings
    • 12.11.3 Key Financial Summary
  • 12.12 Asuragen Inc.
    • 12.12.1 Business Overview
    • 12.12.2 Product and Service Offerings
  • 12.13 Almac Group Limited
    • 12.13.1 Business Overview
    • 12.13.2 Product and Service Offerings
  • 12.14 International Business Machines Corporation
    • 12.14.1 Business Overview
    • 12.14.2 Product and Service Offerings
    • 12.14.3 Key Financial Summary
  • 12.15 Bristol-Myers Squibb Company
    • 12.15.1 Business Overview
    • 12.15.2 Product and Service Offerings
    • 12.15.3 Key Financial Summary
  • 12.16 Johnson & Johnson
    • 12.16.1 Business Overview
    • 12.16.2 Product and Service Offerings
    • 12.16.3 Key Financial Summary
  • 12.17 Eli Lilly and Company
    • 12.17.1 Business Overview
    • 12.17.2 Product and Service Offerings
    • 12.17.3 Key Financial Summary
  • 12.18 Sanofi
    • 12.18.1 Business Overview
    • 12.18.2 Product and Service Offerings
    • 12.18.3 Key Financial Summary
  • 12.19 Abbott Laboratories
    • 12.19.1 Business Overview
    • 12.19.2 Product and Service Offerings
    • 12.19.3 Key Financial Summary
  • 12.20 Bio-Rad Laboratories Inc.
    • 12.20.1 Business Overview
    • 12.20.2 Product and Service Offerings
    • 12.20.3 Key Financial Summary
  • 12.21 Danaher Corporation
    • 12.21.1 Business Overview
    • 12.21.2 Product and Service Offerings
    • 12.21.3 Key Financial Summary
  • 12.22 F. Hoffmann-La Roche Ltd.
    • 12.22.1 Business Overview
    • 12.22.2 Product and Service Offerings
    • 12.22.3 Key Financial Summary
  • 12.23 bioMerieux S.A.
    • 12.23.1 Business Overview
    • 12.23.2 Product and Service Offerings
    • 12.23.3 Key Financial Summary
  • 12.24 General Electric Company
    • 12.24.1 Business Overview
    • 12.24.2 Product and Service Offerings
    • 12.24.3 Key Financial Summary
  • 12.25 Thermo Fisher Scientific Inc.
    • 12.25.1 Business Overview
    • 12.25.2 Product and Service Offerings
    • 12.25.3 Key Financial Summary

Chapter 13. Appendix

  • 13.1 Abbreviations
  • 11.16 Sources and References
  • 13.2 Related Reports

LIST OF TABLES

  • TABLE 1 ANALYSIS PERIOD OF THE STUDY
  • TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 3 RETRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 4 GLOBAL PRECISION MEDICINE MARKET, BY TYPE, $B (2014-2019)
  • TABLE 5 GLOBAL PRECISION MEDICINE MARKET, BY TYPE, $B (2020-2030)
  • TABLE 6 GLOBAL PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $B (2014-2019)
  • TABLE 7 GLOBAL PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $B (2020-2030)
  • TABLE 8 GLOBAL PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $B (2014-2019)
  • TABLE 9 GLOBAL PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $B (2020-2030)
  • TABLE 10 GLOBAL TELEMEDICINE MARKET, BY SERVICE, $B (2014-2019)
  • TABLE 11 GLOBAL TELEMEDICINE MARKET, BY SERVICE, $B (2020-2030)
  • TABLE 12 GLOBAL TELEMEDICINE MARKET, BY SPECIALTY, $B (2014-2019)
  • TABLE 13 GLOBAL TELEMEDICINE MARKET, BY SPECIALTY, $B (2020-2030)
  • TABLE 14 GLOBAL PRECISION MEDICINE MARKET, BY REGION, $B (2014-2019)
  • TABLE 15 GLOBAL PRECISION MEDICINE MARKET, BY REGION, $B (2020-2030)
  • TABLE 16 NORTH AMERICA PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 17 NORTH AMERICA PRECISION MEDICINE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 18 NORTH AMERICA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 19 NORTH AMERICA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 20 NORTH AMERICA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 21 NORTH AMERICA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 22 NORTH AMERICA TELEMEDICINE MARKET, BY SERVICE, $M (2014-2019)
  • TABLE 23 NORTH AMERICA TELEMEDICINE MARKET, BY SERVICE, $M (2020-2030)
  • TABLE 24 NORTH AMERICA TELEMEDICINE MARKET, BY SPECIALTY, $M (2014-2019)
  • TABLE 25 NORTH AMERICA TELEMEDICINE MARKET, BY SPECIALTY, $M (2020-2030)
  • TABLE 26 NORTH AMERICA PRECISION MEDICINE MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 27 NORTH AMERICA PRECISION MEDICINE MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 28 U.S. PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 29 U.S. PRECISION MEDICINE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 30 U.S. PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 31 U.S. PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 32 U.S. PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 33 U.S. PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 34 U.S. TELEMEDICINE MARKET, BY SERVICE, $M (2014-2019)
  • TABLE 35 U.S. TELEMEDICINE MARKET, BY SERVICE, $M (2020-2030)
  • TABLE 36 U.S. TELEMEDICINE MARKET, BY SPECIALTY, $M (2014-2019)
  • TABLE 37 U.S. TELEMEDICINE MARKET, BY SPECIALTY, $M (2020-2030)
  • TABLE 38 CANADA PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 39 CANADA PRECISION MEDICINE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 40 CANADA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 41 CANADA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 42 CANADA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 43 CANADA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 44 CANADA TELEMEDICINE MARKET, BY SERVICE, $M (2014-2019)
  • TABLE 45 CANADA TELEMEDICINE MARKET, BY SERVICE, $M (2020-2030)
  • TABLE 46 CANADA TELEMEDICINE MARKET, BY SPECIALTY, $M (2014-2019)
  • TABLE 47 CANADA TELEMEDICINE MARKET, BY SPECIALTY, $M (2020-2030)
  • TABLE 48 EUROPE PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 49 EUROPE PRECISION MEDICINE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 50 EUROPE PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 51 EUROPE PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 52 EUROPE PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 53 EUROPE PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 54 EUROPE TELEMEDICINE MARKET, BY SERVICE, $M (2014-2019)
  • TABLE 55 EUROPE TELEMEDICINE MARKET, BY SERVICE, $M (2020-2030)
  • TABLE 56 EUROPE TELEMEDICINE MARKET, BY SPECIALTY, $M (2014-2019)
  • TABLE 57 EUROPE TELEMEDICINE MARKET, BY SPECIALTY, $M (2020-2030)
  • TABLE 58 EUROPE PRECISION MEDICINE MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 59 EUROPE PRECISION MEDICINE MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 60 GERMANY PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 61 GERMANY PRECISION MEDICINE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 62 GERMANY PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 63 GERMANY PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 64 GERMANY PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 65 GERMANY PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 66 GERMANY TELEMEDICINE MARKET, BY SERVICE, $M (2014-2019)
  • TABLE 67 GERMANY TELEMEDICINE MARKET, BY SERVICE, $M (2020-2030)
  • TABLE 68 GERMANY TELEMEDICINE MARKET, BY SPECIALTY, $M (2014-2019)
  • TABLE 69 GERMANY TELEMEDICINE MARKET, BY SPECIALTY, $M (2020-2030)
  • TABLE 70 FRANCE PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 71 FRANCE PRECISION MEDICINE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 72 FRANCE PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 73 FRANCE PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 74 FRANCE PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 75 FRANCE PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 76 FRANCE TELEMEDICINE MARKET, BY SERVICE, $M (2014-2019)
  • TABLE 77 FRANCE TELEMEDICINE MARKET, BY SERVICE, $M (2020-2030)
  • TABLE 78 FRANCE TELEMEDICINE MARKET, BY SPECIALTY, $M (2014-2019)
  • TABLE 79 FRANCE TELEMEDICINE MARKET, BY SPECIALTY, $M (2020-2030)
  • TABLE 80 U.K. PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 81 U.K. PRECISION MEDICINE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 82 U.K. PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 83 U.K. PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 84 U.K. PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 85 U.K. PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 86 U.K. TELEMEDICINE MARKET, BY SERVICE, $M (2014-2019)
  • TABLE 87 U.K. TELEMEDICINE MARKET, BY SERVICE, $M (2020-2030)
  • TABLE 88 U.K. TELEMEDICINE MARKET, BY SPECIALTY, $M (2014-2019)
  • TABLE 89 U.K. TELEMEDICINE MARKET, BY SPECIALTY, $M (2020-2030)
  • TABLE 90 ITALY PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 91 ITALY PRECISION MEDICINE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 92 ITALY PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 93 ITALY PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 94 ITALY PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 95 ITALY PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 96 ITALY TELEMEDICINE MARKET, BY SERVICE, $M (2014-2019)
  • TABLE 97 ITALY TELEMEDICINE MARKET, BY SERVICE, $M (2020-2030)
  • TABLE 98 ITALY TELEMEDICINE MARKET, BY SPECIALTY, $M (2014-2019)
  • TABLE 99 ITALY TELEMEDICINE MARKET, BY SPECIALTY, $M (2020-2030)
  • TABLE 100 SPAIN PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 101 SPAIN PRECISION MEDICINE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 102 SPAIN PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 103 SPAIN PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 104 SPAIN PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 105 SPAIN PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 106 SPAIN TELEMEDICINE MARKET, BY SERVICE, $M (2014-2019)
  • TABLE 107 SPAIN TELEMEDICINE MARKET, BY SERVICE, $M (2020-2030)
  • TABLE 108 SPAIN TELEMEDICINE MARKET, BY SPECIALTY, $M (2014-2019)
  • TABLE 109 SPAIN TELEMEDICINE MARKET, BY SPECIALTY, $M (2020-2030)
  • TABLE 110 APAC PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 111 APAC PRECISION MEDICINE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 112 APAC PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 113 APAC PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 114 APAC PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 115 APAC PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 116 APAC TELEMEDICINE MARKET, BY SERVICE, $M (2014-2019)
  • TABLE 117 APAC TELEMEDICINE MARKET, BY SERVICE, $M (2020-2030)
  • TABLE 118 APAC TELEMEDICINE MARKET, BY SPECIALTY, $M (2014-2019)
  • TABLE 119 APAC TELEMEDICINE MARKET, BY SPECIALTY, $M (2020-2030)
  • TABLE 120 APAC PRECISION MEDICINE MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 121 APAC PRECISION MEDICINE MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 122 JAPAN PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 123 JAPAN PRECISION MEDICINE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 124 JAPAN PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 125 JAPAN PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 126 JAPAN PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 127 JAPAN PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 128 JAPAN TELEMEDICINE MARKET, BY SERVICE, $M (2014-2019)
  • TABLE 129 JAPAN TELEMEDICINE MARKET, BY SERVICE, $M (2020-2030)
  • TABLE 130 JAPAN TELEMEDICINE MARKET, BY SPECIALTY, $M (2014-2019)
  • TABLE 131 JAPAN TELEMEDICINE MARKET, BY SPECIALTY, $M (2020-2030)
  • TABLE 132 CHINA PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 133 CHINA PRECISION MEDICINE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 134 CHINA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 135 CHINA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 136 CHINA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 137 CHINA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 138 CHINA TELEMEDICINE MARKET, BY SERVICE, $M (2014-2019)
  • TABLE 139 CHINA TELEMEDICINE MARKET, BY SERVICE, $M (2020-2030)
  • TABLE 140 CHINA TELEMEDICINE MARKET, BY SPECIALTY, $M (2014-2019)
  • TABLE 141 CHINA TELEMEDICINE MARKET, BY SPECIALTY, $M (2020-2030)
  • TABLE 142 INDIA PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 143 INDIA PRECISION MEDICINE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 144 INDIA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 145 INDIA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 146 INDIA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 147 INDIA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 148 INDIA TELEMEDICINE MARKET, BY SERVICE, $M (2014-2019)
  • TABLE 149 INDIA TELEMEDICINE MARKET, BY SERVICE, $M (2020-2030)
  • TABLE 150 INDIA TELEMEDICINE MARKET, BY SPECIALTY, $M (2014-2019)
  • TABLE 151 INDIA TELEMEDICINE MARKET, BY SPECIALTY, $M (2020-2030)
  • TABLE 152 LATAM PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 153 LATAM PRECISION MEDICINE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 154 LATAM PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 155 LATAM PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 156 LATAM PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 157 LATAM PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 158 LATAM TELEMEDICINE MARKET, BY SERVICE, $M (2014-2019)
  • TABLE 159 LATAM TELEMEDICINE MARKET, BY SERVICE, $M (2020-2030)
  • TABLE 160 LATAM TELEMEDICINE MARKET, BY SPECIALTY, $M (2014-2019)
  • TABLE 161 LATAM TELEMEDICINE MARKET, BY SPECIALTY, $M (2020-2030)
  • TABLE 162 LATAM PRECISION MEDICINE MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 163 LATAM PRECISION MEDICINE MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 164 MEA PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 165 MEA PRECISION MEDICINE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 166 MEA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 167 MEA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 168 MEA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 169 MEA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 170 MEA TELEMEDICINE MARKET, BY SERVICE, $M (2014-2019)
  • TABLE 171 MEA TELEMEDICINE MARKET, BY SERVICE, $M (2020-2030)
  • TABLE 172 MEA TELEMEDICINE MARKET, BY SPECIALTY, $M (2014-2019)
  • TABLE 173 MEA TELEMEDICINE MARKET, BY SPECIALTY, $M (2020-2030)
  • TABLE 174 MEA PRECISION MEDICINE MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 175 MEA PRECISION MEDICINE MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 176 PRODUCT BENCHMARKING OF KEY PLAYERS
  • TABLE 177 MYRIAD GENETICS INC. - AT A GLANCE
  • TABLE 178 MYRIAD GENETICS INC. - KEY FINANCIAL SUMMARY
  • TABLE 179 PACIFIC BIOSCIENCES OF CALIFORNIA INC. - AT A GLANCE
  • TABLE 180 PACIFIC BIOSCIENCES OF CALIFORNIA INC. - KEY FINANCIAL SUMMARY
  • TABLE 181 PARTEK INC. - AT A GLANCE
  • TABLE 182 RANDOX LABORATORIES LTD. - AT A GLANCE
  • TABLE 183 MENARINI SILICON BIOSYSTEMS S.P.A. - AT A GLANCE
  • TABLE 184 ORACLE CORPORATION - AT A GLANCE
  • TABLE 185 ORACLE CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 186 23ANDME INC. - AT A GLANCE
  • TABLE 187 PRECISION BIOLOGIC INCORPORATED - AT A GLANCE
  • TABLE 188 EPIC SCIENCES INC. - AT A GLANCE
  • TABLE 189 INTOMICS - AT A GLANCE
  • TABLE 190 MDXHEALTH SA - AT A GLANCE
  • TABLE 191 TABLE 15 MDXHEALTHM SA - KEY FINANCIAL SUMMARY
  • TABLE 192 ASURAGEN INC. - AT A GLANCE
  • TABLE 193 ALMAC GROUP LIMITED - AT A GLANCE
  • TABLE 194 INTERNATIONAL BUSINESS MACHINES CORPORATION - AT A GLANCE
  • TABLE 195 INTERNATIONAL BUSINESS MACHINES CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 196 BRISTOL-MYERS SQUIBB COMPANY - AT A GLANCE
  • TABLE 197 BRISTOL-MYERS SQUIBB COMPANY - KEY FINANCIAL SUMMARY
  • TABLE 198 JOHNSON & JOHNSON - AT A GLANCE
  • TABLE 199 JOHNSON & JOHNSON - KEY FINANCIAL SUMMARY
  • TABLE 200 ELI LILLY AND COMPANY - AT A GLANCE
  • TABLE 201 ELI LILLY AND COMPANY - KEY FINANCIAL SUMMARY
  • TABLE 202 SANOFI - AT A GLANCE
  • TABLE 203 SANOFI - KEY FINANCIAL SUMMARY
  • TABLE 204 ABBOTT LABORATORIES - AT A GLANCE
  • TABLE 205 ABBOTT LABORATORIES - KEY FINANCIAL SUMMARY
  • TABLE 206 BIO-RAD LABORATORIES INC. - AT A GLANCE
  • TABLE 207 BIO-RAD LABORATORIES INC. - KEY FINANCIAL SUMMARY
  • TABLE 208 DANAHER CORPORATION - AT A GLANCE
  • TABLE 209 DANAHER CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 210 F. HOFFMANN-LA ROCHE LTD. - AT A GLANCE
  • TABLE 211 F. HOFFMANN-LA ROCHE LTD. - KEY FINANCIAL SUMMARY
  • TABLE 212 BIOMERIEUX S.A. - AT A GLANCE
  • TABLE 213 BIOMERIEUX S.A. - KEY FINANCIAL SUMMARY
  • TABLE 214 GENERAL ELECTRIC COMPANY - AT A GLANCE
  • TABLE 215 GENERAL ELECTRIC COMPANY - KEY FINANCIAL SUMMARY
  • TABLE 216 THERMO FISHER SCIENTIFIC INC. - AT A GLANCE
  • TABLE 217 THERMO FISHER SCIENTIFIC INC. - KEY FINANCIAL SUMMARY

LIST OF FIGURES

  • FIG 1 RESEARCH SCOPE
  • FIG 2 RESEARCH METHODOLOGY
  • FIG 3 BREAKDOWN OF PRIMARY RESEARCH BY REGION
  • FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
  • FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
  • FIG 6 DATA TRIANGULATION APPROACH
  • FIG 7 GLOBAL PRECISION MEDICINE MARKET SUMMARY
  • FIG 8 NUMBER OF APPROVED PRECISION MEDICINE (2008-2016)
  • FIG 9 BARGAINING POWER OF SUPPLIERS
  • FIG 10 BARGAINING POWER OF BUYERS
  • FIG 11 INTENSITY OF RIVALRY
  • FIG 12 THREAT OF NEW ENTRANTS
  • FIG 13 THREAT OF SUBSTITUTES
  • FIG 14 GLOBAL PRECISION MEDICINE MARKET SNAPSHOT
  • FIG 15 GLOBAL PRECISION MEDICINE MARKET, BY TYPE, $B (2014-2030)
  • FIG 16 GLOBAL PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $B (2014-2030)
  • FIG 17 GLOBAL PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $B (2014-2030)
  • FIG 18 GLOBAL TELEMEDICINE MARKET, BY SERVICE, $B (2014-2030)
  • FIG 19 GLOBAL TELEMEDICINE MARKET, BY SPECIALTY, $B (2014-2030)
  • FIG 20 WORLDWIDE MAJOR MARKETS FOR PRECISION MEDICINE
  • FIG 21 NORTH AMERICA PRECISION MEDICINE MARKET SNAPSHOT
  • FIG 22 NORTH AMERICA PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2030)
  • FIG 23 NORTH AMERICA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2030)
  • FIG 24 NORTH AMERICA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2030)
  • FIG 25 NORTH AMERICA TELEMEDICINE MARKET, BY SERVICE, $M (2014-2030)
  • FIG 26 NORTH AMERICA TELEMEDICINE MARKET, BY SPECIALTY, $M (2014-2030)
  • FIG 27 NORTH AMERICA PRECISION MEDICINE MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 28 U.S. PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2030)
  • FIG 29 U.S. PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2030)
  • FIG 30 U.S. PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2030)
  • FIG 31 CANADA PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2030)
  • FIG 32 CANADA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2030)
  • FIG 33 CANADA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2030)
  • FIG 34 EUROPE PRECISION MEDICINE MARKET SNAPSHOT
  • FIG 35 EUROPE PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2030)
  • FIG 36 EUROPE PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2030)
  • FIG 37 EUROPE PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2030)
  • FIG 38 EUROPE TELEMEDICINE MARKET, BY SERVICE, $M (2014-2030)
  • FIG 39 EUROPE TELEMEDICINE MARKET, BY SPECIALTY, $M (2014-2030)
  • FIG 40 EUROPE PRECISION MEDICINE MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 41 GERMANY PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2030)
  • FIG 42 GERMANY PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2030)
  • FIG 43 GERMANY PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2030)
  • FIG 44 FRANCE PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2030)
  • FIG 45 FRANCE PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2030)
  • FIG 46 FRANCE PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2030)
  • FIG 47 U.K. PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2030)
  • FIG 48 U.K. PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2030)
  • FIG 49 U.K. PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2030)
  • FIG 50 ITALY PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2030)
  • FIG 51 ITALY PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2030)
  • FIG 52 ITALY PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2030)
  • FIG 53 SPAIN PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2030)
  • FIG 54 SPAIN PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2030)
  • FIG 55 SPAIN PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2030)
  • FIG 56 APAC PRECISION MEDICINE MARKET SNAPSHOT
  • FIG 57 APAC PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2030)
  • FIG 58 APAC PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2030)
  • FIG 59 APAC PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2030)
  • FIG 60 APAC TELEMEDICINE MARKET, BY SERVICE, $M (2014-2030)
  • FIG 61 APAC TELEMEDICINE MARKET, BY SPECIALTY, $M (2014-2030)
  • FIG 62 APAC PRECISION MEDICINE MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 63 JAPAN PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2030)
  • FIG 64 JAPAN PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2030)
  • FIG 65 JAPAN PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2030)
  • FIG 66 CHINA PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2030)
  • FIG 67 CHINA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2030)
  • FIG 68 CHINA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2030)
  • FIG 69 INDIA PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2030)
  • FIG 70 INDIA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2030)
  • FIG 71 INDIA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2030)
  • FIG 72 LATAM PRECISION MEDICINE MARKET SNAPSHOT
  • FIG 73 LATAM PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2030)
  • FIG 74 LATAM PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2030)
  • FIG 75 LATAM PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2030)
  • FIG 76 LATAM TELEMEDICINE MARKET, BY SERVICE, $M (2014-2030)
  • FIG 77 LATAM TELEMEDICINE MARKET, BY SPECIALTY, $M (2014-2030)
  • FIG 78 LATAM PRECISION MEDICINE MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 79 MEA PRECISION MEDICINE MARKET SNAPSHOT
  • FIG 80 MEA PRECISION MEDICINE MARKET, BY TYPE, $M (2014-2030)
  • FIG 81 MEA PRECISION MEDICINE DIAGNOSTICS MARKET, BY TYPE, $M (2014-2030)
  • FIG 82 MEA PERSONALIZED MEDICAL CARE MARKET, BY TYPE, $M (2014-2030)
  • FIG 83 MEA TELEMEDICINE MARKET, BY SERVICE, $M (2014-2030)
  • FIG 84 MEA TELEMEDICINE MARKET, BY SPECIALTY, $M (2014-2030)
  • FIG 85 MEA PRECISION MEDICINE MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 86 MYRIAD GENETICS INC. - REVENUE SPLIT BY SEGMENT (2020)
  • FIG 87 PACIFIC BIOSCIENCES OF CALIFORNIA INC. - REVENUE SPLIT BY GEOGRAPHY (2019)
  • FIG 88 ORACLE CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
  • FIG 89 MDXHEALTHM SA - REVENUE BY GEOGRAPHY (2019)
  • FIG 90 INTERNATIONAL BUSINESS MACHINES CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 91 BRISTOL-MYERS SQUIBB COMPANY - REVENUE SPLIT BY GEOGRAPHY (2019)
  • FIG 92 JOHNSON & JOHNSON - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 93 ELI LILLY AND COMPANY - REVENUE SPLIT BY THERAPEUTIC AREA AND GEOGRAPHY (2019)
  • FIG 94 SANOFI - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 95 ABBOTT LABORATORIES - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 96 BIO-RAD LABORATORIES INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 97 DANAHER CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 98 F. HOFFMANN-LA ROCHE LTD. - REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2019)
  • FIG 99 BIOMERIEUX S.A. - REVENUE SPLIT BY APPLICATION AND GEOGRAPHY (2018)
  • FIG 100 GENERAL ELECTRIC COMPANY - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 101 THERMO FISHER SCIENTIFIC INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)